Atrium Therapeutics, Inc. in brief
Atrium Therapeutics, Inc. is a listed company in the Biotechnology industry, based in San Diego, California, USA. Its shares trade under the symbol RNA (Nasdaq).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
Atrium Therapeutics, Inc. timeline
- 2025
- β’Β· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
Events of Atrium Therapeutics, Inc. from SEC EDGAR. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
Not enough history yet.
Quarterly results
Latest quarter to Sep 2026: revenue $15M (+24.1% on a year earlier), net income $-4M.
SEC filings
- Nov 12, 202610-QQuarterly report Β· period to Sep 2026
- Nov 12, 20268-KCurrent reportResults of operations
- Nov 2, 20268-KCurrent reportRegulation FD disclosure Β· Other events
- Oct 27, 20268-KCurrent reportOther events
- Oct 9, 20268-K/ACurrent report (amended)Other events
- Oct 8, 20268-KCurrent reportMaterial agreement Β· Unregistered share sale Β· Other events
- Aug 13, 202610-QQuarterly report Β· period to Jun 2026
- Aug 13, 20268-KCurrent reportResults of operations
- Jul 14, 20268-KCurrent reportOther events
- May 14, 202610-QQuarterly report Β· period to Mar 2026
- May 14, 20268-KCurrent reportResults of operations
- Feb 27, 20268-KCurrent reportMaterial agreement Β· Change in control Β· Directors or officers changed
Official filings of Atrium Therapeutics, Inc. with the US Securities and Exchange Commission.
Balance sheet
- Total assets
- $8 M
- Total liabilities
- $71 M
- Total equity
- $-63 M
As of December-2025
Top 100 institutional investors in Atrium Therapeutics, Inc.#
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 1 | Sessa Capital IM, L.P. | 1,500,000 | 0 (0.00%) | 6.95% | $12 M | Nov 16, 2026 |
| 2 | BlackRock, Inc. | 1,218,522 | -228,954 (-15.82%) | 5.65% | $10 M | Nov 13, 2026 |
| 3 | Vanguard Capital Management LLC | 730,026 | -805 (-0.11%) | 3.38% | $6 M | Nov 13, 2026 |
| 4 | Price T Rowe Associates Inc /MD/ | 640,034 | -832,950 (-56.55%) | 2.97% | $5 M | Nov 16, 2026 |
| 5 | O'Connor Alternative Investments, LLC | 559,142 | -37,876 (-6.34%) | 2.59% | $5 M | Nov 16, 2026 |
| 6 | Bracebridge Capital, LLC | 524,477 | +385,238 (+276.67%) | 2.43% | $4 M | Nov 16, 2026 |
| 7 | TIG Advisors, LLC | 506,926 | -54,607 (-9.72%) | 2.35% | $4 M | Nov 16, 2026 |
| 8 | Bank Of America Corp /de/ | 467,822 | +334,989 (+252.19%) | 2.17% | $4 M | Nov 16, 2026 |
| 9 | Two Sigma Investments, LP | 427,384 | +81,903 (+23.71%) | 1.98% | $4 M | Nov 16, 2026 |
| 10 | Geode Capital Management, LLC | 379,816 | -7,113 (-1.84%) | 1.76% | $3 M | Nov 6, 2026 |
| 11 | Schonfeld Strategic Advisors LLC | 331,531 | +132,373 (+66.47%) | 1.54% | $3 M | Nov 16, 2026 |
| 12 | Los Angeles Capital Management LLC | 321,486 | +290,009 (+921.34%) | 1.49% | $3 M | Nov 12, 2026 |
| 13 | Arbiter Partners Capital Management LLC | 311,719 | -472,145 (-60.23%) | 1.45% | $3 M | Nov 12, 2026 |
| 14 | Goldman Sachs Group Inc | 300,212 | -10,129 (-3.26%) | 1.39% | $2 M | Nov 16, 2026 |
| 15 | DAFNA Capital Management LLC | 300,076 | +172,076 (+134.43%) | 1.39% | $2 M | Nov 16, 2026 |
| 16 | State Street Corp | 291,023 | +19,261 (+7.09%) | 1.35% | $2 M | Nov 12, 2026 |
| 17 | ADAR1 Capital Management, LLC | 267,586 | +209,898 (+363.85%) | 1.24% | $2 M | Nov 16, 2026 |
| 18 | Citadel Advisors LLC | 218,447 | +150,808 (+222.96%) | 1.01% | $2 M | Nov 16, 2026 |
| 19 | BlueCrest Capital Management Ltd | 200,000 | +100,000 (+100.00%) | 0.93% | $2 M | Nov 13, 2026 |
| 20 | Quantinno Capital Management LP | 178,818 | +151,400 (+552.19%) | 0.83% | $1 M | Nov 13, 2026 |
| 21 | Yakira Capital Management, Inc. | 178,316 | +45,269 (+34.02%) | 0.83% | $1 M | Nov 13, 2026 |
| 22 | Polar Asset Management Partners Inc. | 163,200 | +13,200 (+8.80%) | 0.76% | $1 M | Nov 16, 2026 |
| 23 | Nexpoint Asset Management, L.P. | 150,025 | 0 (0.00%) | 0.70% | $1 M | Nov 16, 2026 |
| 24 | AWM Investment Company, Inc. | 150,000 | +42,500 (+39.53%) | 0.70% | $1 M | Nov 13, 2026 |
| 25 | Millennium Management LLC | 147,661 | -52,898 (-26.38%) | 0.68% | $1 M | Nov 16, 2026 |
Show all 100: investors 26 to 100
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 26 | Tudor Investment Corp Et Al | 140,874 | +11,283 (+8.71%) | 0.65% | $1 M | Nov 16, 2026 |
| 27 | Nomura Holdings Inc | 137,417 | +23 (+0.02%) | 0.64% | $1 M | Nov 16, 2026 |
| 28 | Charles Schwab Investment Management Inc | 137,045 | +6,828 (+5.24%) | 0.64% | $1 M | Nov 16, 2026 |
| 29 | Northern Trust Corp | 118,584 | -1,197 (-1.00%) | 0.55% | $1 M | Nov 16, 2026 |
| 30 | Groupe la Francaise | 116,273 | +36,000 (+44.85%) | 0.54% | $1 M | Nov 12, 2026 |
| 31 | Credit Industriel Et Commercial | 113,723 | +24,000 (+26.75%) | 0.53% | $1 M | Nov 13, 2026 |
| 32 | Kalehua Capital Management LLC | 112,652 | New | 0.52% | $1 M | Nov 13, 2026 |
| 33 | Squarepoint Ops LLC | 112,535 | -34,208 (-23.31%) | 0.52% | $1 M | Nov 9, 2026 |
| 34 | Cantor Fitzgerald, L. P. | 111,331 | -402,503 (-78.33%) | 0.52% | $1 M | Nov 16, 2026 |
| 35 | Vanguard Fiduciary Trust Co | 110,241 | +280 (+0.25%) | 0.51% | $1 M | Nov 13, 2026 |
| 36 | Athos Capital Ltd | 107,965 | 0 (0.00%) | 0.50% | $1 M | Nov 13, 2026 |
| 37 | Qube Research & Technologies Ltd | 106,532 | New | 0.49% | $1 M | Nov 13, 2026 |
| 38 | Marble Bar Asset Management LLP | 103,898 | +49 (+0.05%) | 0.48% | $1 M | Nov 16, 2026 |
| 39 | Vanguard Portfolio Management LLC | 102,955 | +1,760 (+1.74%) | 0.48% | $1 M | Nov 13, 2026 |
| 40 | Balyasny Asset Management L.P. | 102,041 | -3,834 (-3.62%) | 0.47% | $1 M | Nov 16, 2026 |
| 41 | Adage Capital Partners GP, L.L.C. | 100,000 | 0 (0.00%) | 0.46% | $1 M | Nov 16, 2026 |
| 42 | Morgan Stanley | 80,112 | +38,170 (+91.01%) | 0.37% | $1 M | Nov 13, 2026 |
| 43 | Acadian Asset Management LLC | 78,834 | New | 0.37% | $1 M | Nov 9, 2026 |
| 44 | Jacobs Levy Equity Management, Inc | 67,565 | +13,573 (+25.14%) | 0.31% | $1 M | Nov 16, 2026 |
| 45 | Jane Street Group, LLC | 63,752 | -46,058 (-41.94%) | 0.30% | $1 M | Nov 12, 2026 |
| 46 | ExodusPoint Capital Management, LP | 62,227 | -55,048 (-46.94%) | 0.29% | $1 M | Nov 16, 2026 |
| 47 | Kennedy Capital Management LLC | 61,255 | +26,276 (+75.12%) | 0.28% | $1 M | Nov 13, 2026 |
| 48 | Prelude Capital Management, LLC | 60,438 | New | 0.28% | $1 M | Nov 16, 2026 |
| 49 | Marshall Wace, LLP | 59,327 | New | 0.28% | $0 M | Nov 13, 2026 |
| 50 | Trium Capital LLP | 58,382 | -54,896 (-48.46%) | 0.27% | $0 M | Oct 16, 2026 |
| 51 | FMR LLC | 55,892 | +22,360 (+66.68%) | 0.26% | $0 M | Nov 10, 2026 |
| 52 | Mercer Global Advisors Inc /adv | 48,150 | New | 0.22% | $0 M | Nov 16, 2026 |
| 53 | Prudential Financial Inc | 46,526 | New | 0.22% | $0 M | Nov 16, 2026 |
| 54 | Oddo BHF Asset Management Sas | 45,090 | 0 (0.00%) | 0.21% | $0 M | Nov 16, 2026 |
| 55 | Caxton Associates LLP | 44,230 | 0 (0.00%) | 0.20% | $0 M | Nov 13, 2026 |
| 56 | Alethea Capital Management, LLC | 43,758 | 0 (0.00%) | 0.20% | $0 M | Nov 13, 2026 |
| 57 | Algert Global LLC | 40,180 | New | 0.19% | $0 M | Nov 17, 2026 |
| 58 | Slotnik Capital, LLC | 39,930 | -197,707 (-83.20%) | 0.19% | $0 M | Nov 16, 2026 |
| 59 | Bank of New York Mellon Corp | 38,324 | -928 (-2.36%) | 0.18% | $0 M | Nov 5, 2026 |
| 60 | XTX Topco Ltd | 37,422 | New | 0.17% | $0 M | Nov 16, 2026 |
| 61 | Gabelli Funds LLC | 36,312 | New | 0.17% | $0 M | Nov 12, 2026 |
| 62 | Jump Financial, LLC | 33,676 | +2,659 (+8.57%) | 0.16% | $0 M | Nov 13, 2026 |
| 63 | LMR Partners LLP | 32,500 | 0 (0.00%) | 0.15% | $0 M | Nov 16, 2026 |
| 64 | Nuveen, LLC | 31,098 | +27 (+0.09%) | 0.14% | $0 M | Nov 10, 2026 |
| 65 | AQR Capital Management LLC | 30,976 | -141,259 (-82.02%) | 0.14% | $0 M | Nov 16, 2026 |
| 66 | GABELLI & Co INVESTMENT ADVISERS, INC. | 30,700 | New | 0.14% | $0 M | Nov 12, 2026 |
| 67 | Point72 Asset Management, L.P. | 28,917 | New | 0.13% | $0 M | Nov 16, 2026 |
| 68 | Weiss Asset Management LP | 28,237 | -191,493 (-87.15%) | 0.13% | $0 M | Nov 16, 2026 |
| 69 | UBS Group AG | 26,483 | +6,911 (+35.31%) | 0.12% | $0 M | Nov 10, 2026 |
| 70 | Renaissance Technologies LLC | 23,700 | +8,729 (+58.31%) | 0.11% | $0 M | Nov 12, 2026 |
| 71 | AlphaCentric Advisors LLC | 22,301 | +8,823 (+65.46%) | 0.10% | $0 M | Nov 3, 2026 |
| 72 | Landscape Capital Management, L.L.C. | 20,158 | New | 0.09% | $0 M | Nov 10, 2026 |
| 73 | Fortress Investment Group LLC | 20,000 | New | 0.09% | $0 M | Nov 16, 2026 |
| 74 | Bridgeway Capital Management, LLC | 19,729 | New | 0.09% | $0 M | Nov 16, 2026 |
| 75 | Empowered Funds, LLC | 19,729 | New | 0.09% | $0 M | Nov 13, 2026 |
| 76 | Russell Investments Group, Ltd. | 19,235 | +14,760 (+329.83%) | 0.09% | $0 M | Nov 6, 2026 |
| 77 | Rhumbline Advisers | 17,111 | +532 (+3.21%) | 0.08% | $0 M | Nov 10, 2026 |
| 78 | Alliancebernstein L.P. | 17,110 | 0 (0.00%) | 0.08% | $0 M | Nov 16, 2026 |
| 79 | Bluefin Capital Management, LLC | 16,011 | 0 (0.00%) | 0.07% | $0 M | Nov 16, 2026 |
| 80 | Axq Capital, LP | 15,885 | +4,508 (+39.62%) | 0.07% | $0 M | Nov 12, 2026 |
| 81 | Caption Management, LLC | 15,145 | -60,132 (-79.88%) | 0.07% | $0 M | Nov 16, 2026 |
| 82 | Invesco Ltd. | 14,692 | +518 (+3.65%) | 0.07% | $0 M | Nov 12, 2026 |
| 83 | Janus Henderson Group Ltd. | 13,833 | β | 0.06% | $0 M | Nov 16, 2026 |
| 84 | Spark Investment Management LLC | 13,300 | New | 0.06% | $0 M | Nov 13, 2026 |
| 85 | Deutsche Bank AG\ | 13,226 | -1,741 (-11.63%) | 0.06% | $0 M | Nov 6, 2026 |
| 86 | Kestra Private Wealth Services, LLC | 12,080 | +1,710 (+16.49%) | 0.06% | $0 M | Nov 6, 2026 |
| 87 | HRT Financial LP | 11,711 | New | 0.05% | $0 M | Nov 13, 2026 |
| 88 | Wealth Enhancement Advisory Services, LLC | 11,709 | New | 0.05% | $0 M | Oct 13, 2026 |
| 89 | Virtu Financial LLC | 11,280 | New | 0.05% | $0 M | Nov 17, 2026 |
| 90 | Jpmorgan Chase & Co | 11,050 | +1,662 (+17.70%) | 0.05% | $0 M | Nov 12, 2026 |
| 91 | Centiva Capital, LP | 10,346 | New | 0.05% | $0 M | Nov 13, 2026 |
| 92 | BNP Paribas Financial Markets | 9,406 | +1,505 (+19.05%) | 0.04% | $0 M | Nov 12, 2026 |
| 93 | Wells Fargo & Company/mn | 9,033 | -8,418 (-48.24%) | 0.04% | $0 M | Nov 16, 2026 |
| 94 | MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 6,948 | +346 (+5.24%) | 0.03% | $0 M | Nov 16, 2026 |
| 95 | Tower Research Capital LLC (TRC) | 6,393 | +4,677 (+272.55%) | 0.03% | $0 M | Nov 16, 2026 |
| 96 | Barclays PLC | 5,856 | +3,157 (+116.97%) | 0.03% | $0 M | Nov 6, 2026 |
| 97 | Vanguard Global Advisers, LLC | 5,582 | -3 (-0.05%) | 0.03% | $0 M | Nov 13, 2026 |
| 98 | Walleye Capital LLC | 4,618 | New | 0.02% | $0 M | Nov 13, 2026 |
| 99 | Skandinaviska Enskilda Banken AB (publ) | 4,400 | 0 (0.00%) | 0.02% | $0 M | Nov 12, 2026 |
| 100 | Strs Ohio | 3,700 | +1,100 (+42.31%) | 0.02% | $0 M | Oct 30, 2026 |
All 148 institutional investors, with who bought and sold β
Mutual funds holding Atrium Therapeutics, Inc.#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| πΊπΈ T. Rowe Price Health Sciences Fund, Inc.T. Rowe Price Associates, Inc. | 566,428 | $8 M | 2.6% | 0.06% | β15% | Jun 30, 2026 |
| πΊπΈ Vanguard Total Stock Market Index FundThe Vanguard Group, Inc. | 518,416 | $7 M | 2.4% | <0.01% | +17% | Jun 30, 2026 |
| πΊπΈ T. Rowe Price New Horizons Fund, Inc.T. Rowe Price Associates, Inc. | 443,263 | $6 M | 2.1% | 0.04% | β0.0% | Jun 30, 2026 |
| πΊπΈ iShares Russell 2000 ETFBlackRock Fund Advisors | 377,354 | $5 M | 1.7% | <0.01% | +26% | Jun 30, 2026 |
| πΊπΈ Vanguard Extended Market Index FundThe Vanguard Group, Inc. | 188,626 | $3 M | 0.87% | <0.01% | +18% | Jun 30, 2026 |
| πΊπΈ BlackRock Event Driven Equity FundBlackRock Advisors, LLC | 175,388 | $2 M | 0.81% | 0.05% | β0.0% | May 29, 2026 |
| πΊπΈ Nexpoint Merger Arbitrage FundNexPoint Asset Management, L.P. | 135,138 | $2 M | 0.63% | 0.12% | no change | Jun 30, 2026 |
| πΊπΈ Fidelity Small Cap Index FundFidelity Management & Research Company LLC | 154,179 | $2 M | 0.71% | <0.01% | +29% | Jul 31, 2026 |
| πΊπΈ iShares Russell 2000 Growth ETFBlackRock Fund Advisors | 88,107 | $1 M | 0.41% | <0.01% | +0.6% | Jun 30, 2026 |
| πΊπΈ Fidelity Extended Market Index FundFidelity Management & Research Company LLC | 73,533 | $1 M | 0.34% | <0.01% | β0.8% | May 31, 2026 |
| πΊπΈ Schwab U.S. Small-Cap ETFCharles Schwab Investment Management, Inc. | 67,639 | $1 M | 0.31% | <0.01% | β1.5% | May 31, 2026 |
| πΊπΈ Vanguard Russell 2000 Index FundThe Vanguard Group, Inc. | 62,889 | $1 M | 0.29% | <0.01% | +9.7% | May 31, 2026 |
| πΊπΈ iShares Micro-Cap ETFBlackRock Fund Advisors | 48,184 | $1 M | 0.22% | 0.04% | new | Jun 30, 2026 |
| πΊπΈ T. Rowe Price Health Sciences PortfolioT. Rowe Price Associates, Inc. | 41,700 | $1 M | 0.19% | 0.07% | no change | Jun 30, 2026 |
| πΊπΈ iShares Russell 2000 Value ETFBlackRock Fund Advisors | 41,090 | $1 M | 0.19% | <0.01% | +400% | Jun 30, 2026 |
| πΊπΈ Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc. | 35,118 | $0 M | 0.16% | <0.01% | +32% | Jul 31, 2026 |
| πΊπΈ Master Small Cap Index SeriesBlackRock Advisors, LLC | 28,368 | $0 M | 0.13% | <0.01% | +47% | Jun 30, 2026 |
| πΊπΈ Fidelity Total Market Index FundFidelity Management & Research Company LLC | 26,529 | $0 M | 0.12% | <0.01% | no change | May 31, 2026 |
| πΊπΈ Fidelity Series Total Market Index FundFidelity Management & Research Company LLC | 21,240 | $0 M | 0.10% | <0.01% | +1.5% | May 31, 2026 |
| πΊπΈ iShares Core S&P Total U.S. Stock Market ETFBlackRock Fund Advisors | 18,530 | $0 M | 0.09% | <0.01% | +3.0% | Jun 30, 2026 |
| πΊπΈ EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC | 17,781 | $0 M | 0.08% | <0.01% | +42% | Jun 30, 2026 |
| πΊπΈ Nuveen Small Cap Blend Index FundTeachers Advisors, LLC | 19,864 | $0 M | 0.09% | <0.01% | +41% | Jul 31, 2026 |
| πΊπΈ Putnam Dynamic Asset Allocation Growth FundFranklin Advisers, Inc. | 14,908 | $0 M | 0.07% | <0.01% | +7244% | Jun 30, 2026 |
| πΊπΈ Health Sciences TrustJohn Hancock Variable Trust Advisers LLC | 14,900 | $0 M | 0.07% | 0.08% | no change | Jun 30, 2026 |
| πΊπΈ Fidelity SAI Merger Arbitrage FundFidelity Diversifying Solutions LLC | 15,000 | $0 M | 0.07% | 0.03% | no change | Jul 31, 2026 |
| πΊπΈ BlackRock Advantage Small Cap Core FundBlackRock Advisors, LLC | 12,237 | $0 M | 0.06% | <0.01% | +2.8% | May 29, 2026 |
| πΊπΈ Fidelity Enhanced Small Cap Core ETFFidelity Management & Research Company LLC | 11,112 | $0 M | 0.05% | <0.01% | +11% | Jun 30, 2026 |
| πΊπΈ EQ/T.Rowe Price Health Sciences PortfolioEquitable Investment Management Group, LLC | 10,400 | $0 M | 0.05% | 0.08% | no change | Jun 30, 2026 |
| πΊπΈ Putnam Dynamic Asset Allocation Balanced FundFranklin Advisers, Inc. | 10,176 | $0 M | 0.05% | <0.01% | +7117% | Jun 30, 2026 |
| πΊπΈ Vanguard Russell 2000 Growth Index FundThe Vanguard Group, Inc. | 10,524 | $0 M | 0.05% | <0.01% | +8.0% | May 31, 2026 |
| πΊπΈ Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P. | 10,078 | $0 M | 0.05% | <0.01% | +3271% | Jun 30, 2026 |
| πΊπΈ Ultra-Small Company Market FundBridgeway Capital Management, LLC | 10,000 | $0 M | 0.05% | 0.09% | new | Jun 30, 2026 |
| πΊπΈ Fidelity Small Cap Growth Index FundFidelity Management & Research Company LLC | 9,178 | $0 M | 0.04% | <0.01% | +7.8% | Jun 30, 2026 |
| πΊπΈ Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC | 8,998 | $0 M | 0.04% | <0.01% | no change | May 31, 2026 |
| πΊπΈ EQ/Small Company Index PortfolioEquitable Investment Management Group, LLC | 8,380 | $0 M | 0.04% | <0.01% | +33% | Jun 30, 2026 |
| πΊπΈ Vanguard Balanced Index FundThe Vanguard Group, Inc. | 8,159 | $0 M | 0.04% | <0.01% | +2.4% | Jun 30, 2026 |
| πΊπΈ Nuveen Equity Index FundTeachers Advisors, LLC | 9,612 | $0 M | 0.04% | <0.01% | no change | Jul 31, 2026 |
| πΊπΈ Multi-Manager Small Cap Equity Strategies FundColumbia Funds Series Trust I | 8,322 | $0 M | 0.04% | <0.01% | new | May 31, 2026 |
| πΊπΈ Schwab U.S. Broad Market ETFCharles Schwab Investment Management, Inc. | 8,226 | $0 M | 0.04% | <0.01% | no change | May 31, 2026 |
| πΊπΈ LVIP State Street Small-Cap Index FundLincoln Financial Investments Corporation | 7,850 | $0 M | 0.04% | <0.01% | no change | Jun 30, 2026 |
| πΊπΈ Small Cap Index FundNorthern Trust Investments, Inc. | 7,436 | $0 M | 0.03% | <0.01% | +12% | Jun 30, 2026 |
| πΊπΈ Vanguard Total World Stock Index FundThe Vanguard Group, Inc. | 8,760 | $0 M | 0.04% | <0.01% | no change | Jul 31, 2026 |
| πΊπΈ Goldman Sachs Small Cap Growth Insights FundGoldman Sachs Asset Management, L.P. | 8,636 | $0 M | 0.04% | 0.03% | β59% | Jul 31, 2026 |
| πΊπΈ Fidelity ZERO Total Market Index FundFidelity Management & Research Company LLC | 8,249 | $0 M | 0.04% | <0.01% | +15% | Jul 31, 2026 |
| πΊπΈ Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc. | 6,870 | $0 M | 0.03% | <0.01% | no change | Jun 30, 2026 |
| πΊπΈ EQ/AB Small Cap Growth PortfolioEquitable Investment Management Group, LLC | 6,080 | $0 M | 0.03% | <0.01% | +52% | Jun 30, 2026 |
| πΊπΈ Schwab Total Stock Market Index FundCharles Schwab Investment Management, Inc. | 7,037 | $0 M | 0.03% | <0.01% | no change | Jul 31, 2026 |
| πΊπΈ Fidelity Small Cap Value Index FundFidelity Management & Research Company LLC | 5,870 | $0 M | 0.03% | <0.01% | +491% | Jun 30, 2026 |
| πΊπΈ Global X Russell 2000 ETFGlobal X Management Company LLC | 6,837 | $0 M | 0.03% | <0.01% | +33% | Jul 31, 2026 |
| πΊπΈ MetLife Russell 2000 Index PortfolioBrighthouse Investment Advisers, LLC | 5,194 | $0 M | 0.02% | <0.01% | +38% | Jun 30, 2026 |
| πΊπΈ Fidelity ZERO Extended Market Index FundFidelity Management & Research Company LLC | 6,145 | $0 M | 0.03% | <0.01% | +19% | Jul 31, 2026 |
| πΊπΈ The Gabelli ABC FundGabelli Funds, LLC | 5,000 | $0 M | 0.02% | 0.02% | no change | Jun 30, 2026 |
| πΊπΈ BlackRock Advantage Small Cap Growth FundBlackRock Funds | 4,913 | $0 M | 0.02% | <0.01% | +29% | Jun 30, 2026 |
| πΊπΈ ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC | 4,573 | $0 M | 0.02% | <0.01% | +31% | Jun 30, 2026 |
| πΊπΈ Small Cap Index FundThe Variable Annuity Life Insurance Company | 4,652 | $0 M | 0.02% | <0.01% | no change | May 31, 2026 |
| πΊπΈ State Street Small/mid Cap Equity Index PortfolioSSGA Funds Management, Inc. | 3,870 | $0 M | 0.02% | <0.01% | no change | Jun 30, 2026 |
| πΊπΈ Schwab 1000 Index FundCharles Schwab Investment Management, Inc. | 4,540 | $0 M | 0.02% | <0.01% | no change | Jul 31, 2026 |
| πΊπΈ SIMT Small Cap FundSEI Institutional Managed Trust | 3,526 | $0 M | 0.02% | <0.01% | new | Jun 30, 2026 |
| πΊπΈ NVIT GS Small Cap Equity Insights FundNATIONWIDE FUND ADVISORS | 3,438 | $0 M | 0.02% | 0.02% | new | Jun 30, 2026 |
| πΊπΈ NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS | 3,342 | $0 M | 0.02% | <0.01% | +47% | Jun 30, 2026 |
| πΊπΈ 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC | 3,246 | $0 M | 0.02% | 0.02% | new | Jun 30, 2026 |
| πΊπΈ iShares Russell 3000 ETFBlackRock Fund Advisors | 3,219 | $0 M | 0.01% | <0.01% | β0.9% | Jun 30, 2026 |
| πΊπΈ Small-Cap Index PortfolioPacific Life Fund Advisors LLC | 3,037 | $0 M | 0.01% | <0.01% | +0.1% | Jun 30, 2026 |
| πΊπΈ Small Cap Index TrustJohn Hancock Variable Trust Advisers LLC | 2,891 | $0 M | 0.01% | <0.01% | +27% | Jun 30, 2026 |
| πΊπΈ Invesco RAFI US 1500 Small-Mid ETFInvesco Capital Management LLC | 2,955 | $0 M | 0.01% | <0.01% | β15% | Jul 31, 2026 |
| πΊπΈ Vanguard Esg U.S. Stock ETFThe Vanguard Group, Inc. | 2,521 | $0 M | 0.01% | <0.01% | β0.0% | May 31, 2026 |
| πΊπΈ DWS Small Cap Index VIPDWS Investment Management Americas, Inc. | 2,245 | $0 M | 0.01% | <0.01% | +37% | Jun 30, 2026 |
| πΊπΈ T. Rowe Price Extended Equity Market Index FundT. Rowe Price Associates, Inc. | 2,227 | $0 M | 0.01% | <0.01% | no change | Jun 30, 2026 |
| πΊπΈ Fidelity Flex Small Cap Index FundFidelity Management & Research Company LLC | 2,598 | $0 M | 0.01% | <0.01% | +23% | Jul 31, 2026 |
| πΊπΈ T. Rowe Price Small-Cap Index FundT. Rowe Price Associates, Inc. | 2,161 | $0 M | 0.01% | <0.01% | +56% | Jun 30, 2026 |
| πΊπΈ Diversified Equity Alpha Master PortfolioBlackRock Fund Advisors | 2,083 | $0 M | <0.01% | <0.01% | β20% | Jun 30, 2026 |
| πΊπΈ Bridge Builder Small/Mid Cap Growth FundOLIVE STREET INVESTMENT ADVISERS LLC | 2,049 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| πΊπΈ Voya RussellTM Small Cap Index PortfolioVoya Investments, LLC | 1,972 | $0 M | <0.01% | <0.01% | +56% | Jun 30, 2026 |
| πΊπΈ T. Rowe Price Total Equity Market Index FundT. Rowe Price Associates, Inc. | 1,886 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| πΊπΈ JPMorgan Small Cap Value FundJ.P. Morgan Investment Management Inc. | 1,788 | $0 M | <0.01% | <0.01% | β5.7% | Jun 30, 2026 |
| πΊπΈ Siit Extended Market Index FundSEI INVESTMENTS MANAGEMENT CORPORATION | 1,820 | $0 M | <0.01% | <0.01% | no change | May 31, 2026 |
| πΊπΈ Putnam Dynamic Asset Allocation Conservative FundFranklin Advisers, Inc. | 1,607 | $0 M | <0.01% | <0.01% | +7552% | Jun 30, 2026 |
| πΊπΈ iShares Russell Small/Mid-Cap Index FundBlackRock Advisors, LLC | 1,809 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| πΊπΈ EQ/Morgan Stanley Small Cap Growth PortfolioEquitable Investment Management Group, LLC | 1,507 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| πΊπΈ EQ/Common Stock Index PortfolioEquitable Investment Management Group, LLC | 1,450 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| πΊπΈ BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC | 1,427 | $0 M | <0.01% | <0.01% | +0.1% | Jun 30, 2026 |
| πΊπΈ AQR Small Cap Momentum Style FundAQR CAPITAL MANAGEMENT, LLC | 1,386 | $0 M | <0.01% | 0.01% | β | Mar 31, 2026 |
| πΊπΈ VIP Disciplined Small Cap PortfolioFidelity Management & Research Company LLC | 1,290 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| πΊπΈ Strategic Advisers U.S. Total Stock FundStrategic Advisers LLC | 1,227 | $0 M | <0.01% | <0.01% | β7.5% | May 31, 2026 |
| πΊπΈ SA Small Cap Index PortfolioSunAmerica Asset Management, LLC | 1,318 | $0 M | <0.01% | <0.01% | +1.9% | Jul 31, 2026 |
| πΊπΈ Putnam Multi-Asset Income FundFranklin Advisers, Inc. | 1,092 | $0 M | <0.01% | <0.01% | +8498% | May 31, 2026 |
| πΊπΈ Schwab 1000 Index ETFCharles Schwab Investment Management, Inc. | 1,088 | $0 M | <0.01% | <0.01% | no change | May 31, 2026 |
| πΊπΈ VIP Extended Market Index PortfolioFidelity Management & Research Company LLC | 1,026 | $0 M | <0.01% | <0.01% | +11% | Jun 30, 2026 |
| πΊπΈ Putnam Dynamic Asset Allocation Equity FundFranklin Advisers, Inc. | 1,049 | $0 M | <0.01% | <0.01% | new | May 31, 2026 |
| πΊπΈ PD Small-Cap Growth Index PortfolioPacific Life Fund Advisors LLC | 968 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| πΊπΈ CVT Russell 2000 Small Cap Index PortfolioCalvert Research and Management | 950 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| πΊπΈ Vanguard Russell 3000 Index FundThe Vanguard Group, Inc. | 933 | $0 M | <0.01% | <0.01% | no change | May 31, 2026 |
| πΊπΈ Venerable Small Cap Index FundVenerable Investment Advisers, LLC | 898 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| πΊπΈ AVIP BlackRock Advantage Small Cap Growth PortfolioCONSTELLATION INVESTMENTS INC | 808 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| πΊπΈ Nationwide Small Cap Index FundNATIONWIDE FUND ADVISORS | 946 | $0 M | <0.01% | <0.01% | +0.6% | Jul 31, 2026 |
| πΊπΈ SA Franklin Allocation Moderately Aggressive PortfolioSunAmerica Asset Management, LLC | 770 | $0 M | <0.01% | <0.01% | +7600% | Jun 30, 2026 |
| πΊπΈ Strategic Equity Allocation TrustJohn Hancock Variable Trust Advisers LLC | 766 | $0 M | <0.01% | <0.01% | β20% | Jun 30, 2026 |
| πΊπΈ 1290 VT Small Cap Value PortfolioEquitable Investment Management Group, LLC | 706 | $0 M | <0.01% | <0.01% | +412% | Jun 30, 2026 |
| πΊπΈ Vanguard Russell 2000 Value Index FundThe Vanguard Group, Inc. | 724 | $0 M | <0.01% | <0.01% | +5.8% | May 31, 2026 |
| πΊπΈ iShares Total U.S. Stock Market Index FundBlackRock Advisors, LLC | 767 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses Β· as of Jul 31, 2026. The 100 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Insider trading at Atrium Therapeutics, Inc.#
Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | W. Michael FlanaganDirector | Shares withheld for tax | -22,812 | $8.950 | $204 K | 31,974 | Form 4 |
| filed | Husam YounisChief Scientific Officer | Shares withheld for tax | -11,216 | $8.950 | $100 K | 41,441 | Form 4 |
| filed | Kathleen P. GallagherSee Remarks, Director | Shares withheld for tax | -11,632 | $8.950 | $104 K | 119,729 | Form 4 |
| filed | Sarah BoyceDirector | Shares withheld for tax | -126,418 | $8.950 | $1.1 M | 138,668 | Form 4 |
| filed | Rocio Martin HoyosChief Strategy Officer | Shares withheld for tax | -8,320 | $8.950 | $74 K | 38,340 | Form 4 |
| filed | Brendan R. WinslowChief Financial Officer | Shares withheld for tax | -6,742 | $8.950 | $60 K | 36,859 | Form 4 |
| filed | Stephanie KenneySee Remarks | Shares withheld for tax | -2,375 | $8.950 | $21 K | 33,085 | Form 4 |
| filed | Steven George HughesChief Medical Officer | Shares withheld for tax | -21,459 | $8.950 | $192 K | 51,638 | Form 4 |
Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals
Atrium Therapeutics, Inc. scorecard#
Passes 0 of the 1 checks that could be worked out. Fiscal year 2025.
Valuationnot known
- βP/E below its peers' medianNo market cap.
- βPrice to book below its peers' medianNo market cap.
- βPrice to sales below its peers' medianNo market cap.
- βFree cash flow yield above 5%No market cap.
- βEarnings yield above the 10-year Treasury yieldNo market cap.
- βThe price assumes slower growth than the last three years'No market cap.
Growthnot known
- βRevenue grew in the newest yearRevenue of the year before is not on file.
- βRevenue up more than 5% a year over three yearsRevenue of three years earlier is not on file.
- βFaster growth over three years than its peers' medianRevenue of three years earlier is not on file.
- βEarnings per share grew in the newest yearEarnings per share of two years are not on file.
- βNet income higher than five years earlierNet income of five years earlier is not on file.
- βRevenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
Profitabilitynot known
- βProfitable in the newest yearNo net income on file.
- βProfitable in each of the last five yearsFive years of net income are not on file.
- βOperating margin above its peers' medianNo operating margin on file.
- βReturn on equity above 15%No return on equity (equity missing or negative).
- βReturn on invested capital above 10%No return on invested capital on file.
- βOperating margin wider than three years earlierOperating margins of three years earlier are not on file.
Financial health0 of 1
- βShort-term assets cover short-term liabilities0.1ΓCurrent ratio 0.07 at the end of fiscal 2025.
- βDebt below equityDebt or equity is not on file (or equity is negative).
- βNet debt below three years of EBITDANet debt to EBITDA is not on file.
- βOperating income covers interest five timesInterest expense is not on file.
- βCash from operations positive in each of the last three yearsThree years of operating cash flow are not on file.
- βAltman Z-score outside the distress zoneThe Z-score's figures are not all on file.
Shareholder returnsnot known
- βPays a dividendDividends are not on file.
- βDividend per share raised five years in a rowSix years of dividends per share are not on file.
- βDividends under 75% of net incomePays no dividend (or dividends are not on file).
- βShare count up no more than 2% in a yearShare counts of two years are not on file.
- βDividends and buybacks above 3% of the market valueNo market cap.
- βFree cash flow covers dividends and buybacksCash from operations or capital spending is not on file.
Worked out from the statements as filed (sec), the medians of Biotechnology, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Events at Atrium Therapeutics, Inc.#
What the company reported to the SEC within four business days (Form 8-K), newest first.
No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.
Change in control 1 Β· Directors and officers 1 Β· Material agreement 2 Β· Unregistered share sale 1 Β· Results announced 3
Source: SEC EDGAR, Form 8-K item numbers Β· as of Nov 12, 2026
Lobbying by Atrium Therapeutics, Inc.#
$190 K spent on lobbying the US Congress and federal agencies in 2026, most often on health issues.
- Health Issues3 reports
Lobbying firms hired in 2026
FEROX STRATEGIES $190 K
| Year | Spending | Own lobbyists | Reports |
|---|---|---|---|
| 2026 (so far) | $190 K | β | 3 |
Source: Lobbying Disclosure Act reports (Form LD-2). Filed as βAtrium Therapeuticsβ. Reports round to the nearest $10,000, and one of less than $5,000 counts as zero
Peer comparison Β· Biotechnology
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Atrium Therapeutics, Inc.πΊπΈ | β | β | β | β |
| Novo Nordisk A/Sπ©π° | $203.2 B | 13.1Γ | 33.1% | +10.8% |
| Vertex Pharmaceuticals IncorporatedπΊπΈ | $134.3 B | 33.8Γ | 30.7% | +8.9% |
| Moderna, Inc.πΊπΈ | $90.1 B | β | -110.5% | -39.9% |
| Regeneron Pharmaceuticals, Inc.πΊπΈ | $84.1 B | 17.5Γ | 28.5% | +1.0% |
| Argenx SEπ³π± | $52.8 B | 40.9Γ | 31.1% | +89.9% |
| CSL Limitedπ¦πΊ | $51.6 B | β | -16.4% | β |
| Samsung Biologics Co., Ltd.π°π· | $51.5 B | 40.5Γ | 39.2% | β |
| UCB SAπ§πͺ | $48.6 B | 26.3Γ | 20.1% | +31.1% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Novo Nordisk A/S$203.2 B
- Vertex Pharmaceuticals Incorporated$134.3 B
- Moderna, Inc.$90.1 B
- Regeneron Pharmaceuticals, Inc.$84.1 B
- Argenx SE$52.8 B
- CSL Limited$51.6 B
Sources and freshness
- Balance sheet:
- As of December-2025
- Profile updated:
- Nov 5, 2026
Figures from value.today research, SEC filing; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Atrium Therapeutics, Inc.? Verify and update this profile β free
Show Atrium Therapeutics, Inc.'s ranking on your website Get the badge
The badge updates itself as the ranking changes.